Algo version: 0.98b
CARM is listed at the NASDAQ Exchange
CARM [CARM]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CARM stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Carisma Therapeutics, pays dividends. Last time was Wednesday 8th of March 2023 where the investors holding the stock on Wednesday 8th of March 2023 were paid $0.01810 per share. Over the last 1 times between 2023 and 2023, Carisma Therapeutics, has paid $0.0181 with an average of $0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Carisma Therapeutics, 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $246.60, you would have made a loss of $-245.60 per share or -99.59%

No, the average daily trading liquidity for Carisma Therapeutics, is $789 785 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Carisma Therapeutics, has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Carisma Therapeutics, to be high [0.85 out of 1]